Skip to content

Clinical trials

Terminated Alzheimer Disease trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Terminated Country / region: South Korea Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20081
20091
20102
20132
20143
20151
20164
20173
20182
20202
20212
20224
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche7
AstraZeneca3
Biogen3
FORUM Pharmaceuticals Inc3
GlaxoSmithKline3
Cassava Sciences, Inc.2
Merck Sharp & Dohme LLC2
Pfizer2
Axovant Sciences Ltd.1
Eisai Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease32
Dementia11
Brain Diseases6
Central Nervous System Diseases5
Mental Disorders5
Nervous System Diseases5
Neurodegenerative Diseases4
Tauopathies4
Neurocognitive Disorders3
Cognitive Dysfunction2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.